Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Accuray Inc (NASDAQ:ARAY)

5.46
Delayed Data
As of 3:59pm ET
 -0.01 / -0.18%
Today’s Change
4.75
Today|||52-Week Range
7.54
-19.11%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$442.7M

Company Description

Accuray, Inc. is the premier radiation oncology company which develops, manufactures and sells personalized treatment solutions such as the cyberKnife and tomotherapy systems, which are designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy and adaptive radiation therapy. The cyberKnife system is designed to combine continual image guidance technology with a compact linear accelerator, or linac, which has the ability to move in three dimensions according to the treatment plan. The tomotherapy system operates on a ring gantry and combines integrated computed tomography, or CT, imaging with intensity modulated radiation therapy, which is designed to deliver radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. Accuray was founded by John R. Adler in 1990 and is headquartered in Sunnyvale, CA.

Contact Information

Accuray, Inc.
1310 Chesapeake Terrace
Sunnyvale California 94089
P:(408) 716-4600
Investor Relations:
(408) 789-4335

Employees

Shareholders

Other institutional52.25%
Mutual fund holders47.96%
Individual stakeholders30.84%

Top Executives

Joshua H. LevinePresident, Chief Executive Officer & Director
Kelly J. LondyChief Operating Officer & Executive Vice President
Kevin WatersChief Financial Officer & Senior Vice President
Robert W. HillSenior Vice President-Research & Development
Ole Steve MikkelsenChief Information Officer & Senior Vice President